 Email this article to a friend  Printable Version FREE Email Newsletter
(NaturalNews) Everywhere you turn these days, drug companies are attempting to associate diseases with viruses as a preamble for a future vaccine push. For the last few years, Pharma-friendly researchers have been claiming prostate cancer might be caused by Xenotropic Murine Leukemia Virus (XMLV) because they've discovered such viruses in prostate cancer tumors.
Similarly, there was a recent push to claim that Chronic Fatigue Syndrome was caused by a virus for the same reason: CFS sufferers seem to have higher counts of the virus than healthy people. But as recently published in a NaturalNews article (http://www.naturalnews.com/027248_d...), it makes more sense that this viral count is a side effect of CFS than a root cause. (Unless, of course, a strange virus was introduced via a vaccine, which is one vector through which such a condition could have been forced onto victims.)
Now, new research published in the journal Retrovirology which looked at the presence of the virus in 589 prostate cancer patients reveals that there is no link between XMRV and prostate cancer. Out of the 589 prostate cancer patients studied, DNA or RNA fragments of XMRV viruses were found in exactly zero patients.
None of the patients even had antibodies for XMRV.
This research reveals quite conclusively that XMRV is not "the" cause of prostate cancer. Obviously, prostate cancer can exist entirely without the presence of XMRV. This doesn't mean, of course, that XMRV doesn't contribute to cancer in some way in those patients where it shows a presence, but it does prove that XMRV is not a requirement for prostate cancer.
As with CFS, the more likely explanation here seems to be that XMRV is only found in prostate cancer patients because cancer is a disease that grows out of control in a suppressed immune system environment. The same immune system that fails to keep cancer in check is also likely to be a poor defender against invading viruses.
As a metaphor, consider this: Paramedics see blood at most traffic accidents. But do they leap to the conclusion that traffic accidents are caused by blood? Of course not. That would be silly.
The presence of blood is simply an unfortunate side effect of the root cause (someone driving on medications, perhaps). So why do prostate cancer researchers leap to the conclusion that the mere presence of a virus in cancer tumors describes a causal relationship between the two? It's an unscientific leap of logic that simply doesn't hold up under scrutiny. And this new German study provides yet more evidence calling into question any such link between XMRV and prostate cancer.
Sources for this story include:
Retrovirology
Oliver Hohn, Hans Krause, Pia Barbarotto, Lars Niederstadt, Nadine Beimforde, Joachim Denner, Kurt Miller, Reinhard Kurth and Norbert Bannert. Lack of evidence for xenotropic murine leukemia virus-related virus (XMRV) in German prostate cancer patients. Retrovirology, 2009
Get articles like this delivered to you FREE in our popular email newsletter
|
(FREE) Thursday evening, Feb. 11 at 6pm Pacific (9pm Eastern), call in to hear the NaturalNews Talk Hour with our special guest John Roulac, Founder of Nutiva. This special show "Superfood Nutrition: Discover the NEWest Trends" will reveal delicious ways to enjoy life. Register via email to receive call-in details:
|
|
Explore NaturalPedia.com, the internet's largest natural health encyclopedia of knowledge, covering over 50,000 topics. It's free!
Visit NaturalPedia.com.
|
 NEW Product: Valley of Longevity Shampoo from the Health Ranger
• 98% Organic
• 100% Natural
• 100% Fragrance Free!
• No SLS
• No Parabens
• No synthetic chemicals
• FREE shipping in U.S. on orders over $75
Click here to read more...
|
 FREE Report: The Five Best Anti-Viral Products to Beat Influenza, Swine Flu, Bird Flu and SARS
• Top anti-viral remedies
• Where to get them now
• Four things to avoid
• Become self-reliant
• Boost your family safety
Click here to read the FREE report now.
|
|
|
Monday, October 19, 2009
Email this article to a friend
Share this article on: 
